文献速递脑血管病外科神经重症

动脉瘤性蛛网膜下腔出血后无症状脑血管痉挛的血管造影治疗以预防迟发性脑缺血

Angiographic Treatment of Asymptomatic Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage for the Prevention of Delayed Cerebral Ischemia.
PubMed 文献 · World Neurosurg · 2022-07-03

该回顾性分析纳入2017年7月至2019年6月连续收治的94例动脉瘤性蛛网膜下腔出血患者,其中37例接受脑血管痉挛筛查,16例(43%)存在中重度血管痉挛。比较接受与未接受治疗性脑血管造影患者的迟发性脑缺血发生率,校正性别、年龄和蛛网膜下腔出血分级后,治疗与迟发性脑缺血无显著关联(风险比=0.82,95%置信区间:0.19-3.52,P=0.79)。重症监护室和住院中位住院时间随脑血管痉挛严重程度显著增加(P<0.001)。

要点

  • 无症状患者中脑血管造影检出中重度脑血管痉挛的比例为43%(16/37)。
  • 治疗性脑血管造影与迟发性脑缺血无显著关联(风险比=0.82,95%置信区间:0.19-3.52,P=0.79)。
  • 脑血管痉挛严重程度与重症监护室及住院中位住院时间显著相关(P<0.001)。

核心结论

  • 脑血管造影在无症状患者中检出中重度脑血管痉挛的比例较低。
  • 无症状患者接受与未接受脑血管痉挛治疗相比,迟发性脑缺血发生率无统计学显著差异。
  • 脑血管痉挛严重程度与重症监护室及住院住院时间存在显著关联。
  • 需要更多研究评估治疗高级别动脉瘤性蛛网膜下腔出血患者无症状脑血管痉挛的效用。

研究设计与样本

  • 回顾性分析2017年7月至2019年6月连续收治的94例动脉瘤性蛛网膜下腔出血患者。
  • 37例患者接受脑血管痉挛筛查,其中16例(43%)存在中重度血管痉挛。
  • 比较接受治疗性脑血管造影的无症状脑血管痉挛患者与未接受者迟发性脑缺血发生率,采用Mann-Whitney U检验或χ2检验比较两组,并校正性别、年龄和蛛网膜下腔出血分级。

主要发现

  • 37例接受筛查的患者中16例(43%)存在中重度血管痉挛。
  • 治疗性脑血管造影与迟发性脑缺血无显著关联(风险比=0.82,95%置信区间:0.19-3.52,P=0.79)。
  • 重症监护室和住院中位住院时间随脑血管痉挛严重程度显著增加(P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Angiographic treatment of asymptomatic cerebral vasospasm (CVS) in aneurysmal subarachnoid hemorrhage remains controversial. We sought to investigate its relationship with the development of delayed cerebral ischemia. METHODS: Consecutive patients admitted between July 2017 and June 2019, with a diagnosis of aneurysmal subarachnoid hemorrhage, were retrospectively analyzed. The rate of development of delayed cerebral ischemia was compared between a group of patients who underwent cerebral angiography for asymptomatic CVS and those who did not. The Mann-Whitney U test or χ2 test was used to compare the 2 groups. RESULTS: Thirty-seven of the 94 patients with aneurysmal subarachnoid hemorrhage were screened for CVS, of whom 16 (43%) had moderate-severe vasospasm. When patients who underwent therapeutic cerebral angiography were compared with those who did not and after adjusting for sex, age, and grade of subarachnoid hemorrhage, treatment was not found to be significantly associated with delayed cerebral ischemia (hazard ratio = 0.82, 95% confidence interval: 0.19-3.52, P = 0.79). We found that the median length of stay in the intensive care unit and hospital increased significantly with the severity of CVS (P < 0.001). CONCLUSIONS: Cerebral angiography has a low rate of detecting moderate-severe CVS in asymptomatic patients. Moreover, there was no statistically significant difference in the rate of delayed cerebral ischemia between asymptomatic patients treated versus those not treated for CVS. There was significant association between the severity of CVS and the intensive care unit and hospital length of stay. More studies are needed to evaluate the utility of treating asymptomatic CVS in high-grade aneurysmal subarachnoid hemorrhage.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Rebeiz T, Sabirov T, Wanchoo S, et al. Angiographic Treatment of Asymptomatic Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage for the Prevention of Delayed Cerebral Ischemia. World Neurosurg. 2022. PMID: 35787959. doi:10.1016/j.wneu.2022.06.129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。